How pharma and CRO leaders should assess Claude use cases

Pharma and CRO leaders should assess Claude use cases against five dimensions — regulatory exposure, data readiness, human-in-the-loop feasibility, commercial value, and operational ownership — and prioritise opportunities that score well across all five rather than chasing the highest single-dimension upside.

• Five-dimension scoring framework for Claude opportunities
• Regulatory exposure and human-in-the-loop feasibility as gating criteria
• Data readiness and governed retrieval as preconditions
• Sequencing the portfolio: quick wins, foundations, and deferred bets